A recent report indicated that activation of this pathway elicits an antitumor response that is subsequently exploited by cancer cells to evade immune surveillance by containing the immune response within the tumor microenvironment at suboptimal levels and promoting tumor metastasis through activation of the noncanonical NF-κB pathway14. This evidence concerns the gene NFKB1 and neoplasm.